Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Consulting with a dermatologist is key to finding the right treatment plan for your specific case
This makes it particularly valuable for patients whose skin sensitivity limits their use of more aggressive actives like retinoids
Results for Phase II Clinical Trial of LCL161, a SMAC Mimetic, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (post-PV MF) or Post-Essential Thrombocytosis Myelofibrosis (post-ET MF)
Cancer Cell 19 , 1730 (2011)
US$ 26.74
US$ 25.32
US$ 26.97
US$ 20.48
US$ 22.14
